🟢 Royalty Pharma is trading 4.17% up today with possible support from healthcare-sector strength

Royalty Pharma is trading at $58.93, up 4.17%, with no clear company-specific catalyst; healthcare-sector strength may have helped.

• Its latest listed company announcement was an AstraZeneca royalty acquisition, published October 10.
• UnitedHealth reported better-than-expected third-quarter adjusted earnings and raised its 2026 outlook.
• Broader markets were weaker amid hotter-than-expected inflation, which does not explain the gain. The sector link is supportive context, not confirmed direct causation.